Simplex Trading’s Nautilus Biotechnolgy NAUT Stock Holding History

Simplex Trading’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.98K	Buy	3,200 +3,100	+3,100%	+$8.19K	﹤0.01%	8065
2026 Q1	$388	Sell	100 -400	-80%	-$983	﹤0.01%	8764
2025 Q4	$975	Buy	+500	New	+$820	﹤0.01%	8032
2023 Q3	–	Sell	-700	Closed	-$2K	–	9411
2023 Q2	$2K	Sell	700 -240,700	-100%	-$693K	﹤0.01%	8458
2023 Q1	$668K	Buy	+241,400	New	+$506K	﹤0.01%	2982
2022 Q3	–	Sell	-1,000	Closed	-$2K	–	10541
2022 Q2	$2K	Sell	1,000 -2,700	-73%	-$10.1K	﹤0.01%	9384
2022 Q1	$16K	Sell	3,700 -5,200	-58%	-$21.3K	﹤0.01%	8468
2021 Q4	$46K	Buy	8,900 +8,800	+8,800%	+$47.1K	﹤0.01%	7370
2021 Q3	$1K	Hold	100	–	–	﹤0.01%	9662
2021 Q2	$1K	Buy	+100	New	+$1.08K	﹤0.01%	9840

Other funds holding NAUT

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

ACM

AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

CFM

Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return

Simplex Trading's NAUT Position: Q2 2026 in Review

Simplex Trading opened a new position in Nautilus Biotechnolgy (NAUT) in Q2 2026: 1,090 shares worth $2.04K. The stake represents ﹤0.01% of the portfolio and ranks #8628 among its holdings. This is a return to the name: Simplex Trading previously reported a position in NAUT as recently as Q2 2025.

Simplex Trading first reported a position in NAUT in Q2 2021 and has held it in 12 quarters since. The position peaked at $418K in Q4 2021. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

Simplex Trading held 1,090 shares of Nautilus Biotechnolgy worth $2.04K as of Q2 2026.
Nautilus Biotechnolgy was a new Simplex Trading position in Q2 2026.
Nautilus Biotechnolgy made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8628 holding.
Simplex Trading first reported a position in Nautilus Biotechnolgy in Q2 2021 and has held it in 12 quarters since.
Simplex Trading's Nautilus Biotechnolgy position peaked at $418K in Q4 2021.
93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.